YuLife is a London-based insurance company founded in 2016 that aims to inspire individuals to lead healthier lives through its innovative insurance and well-being platform. The company combines insurance products with gamification and behavioral science to create plans that not only provide life and medical coverage but also reward users for engaging in health-promoting activities, such as walking and meditation. Users can earn rewards like air miles, vouchers, and gift cards, which support their financial, emotional, and physical well-being. YuLife's approach seeks to transform traditional financial products into tools that encourage a healthier lifestyle, benefiting both individuals and businesses by fostering a culture of wellness. The company is supported by several venture capital firms and investors committed to its mission.
Tessera Therapeutics is an early-stage life sciences company focused on pioneering Gene Writing technology, which allows for the permanent modification of the human genome. This innovative approach enables scientists and clinicians to introduce therapeutic messages into the genome, offering a potential cure for diseases at their source. By building on recent advancements in gene therapy and gene editing, Tessera Therapeutics aims to address significant limitations in these areas, enhancing their applicability and effectiveness. Founded by Flagship Pioneering, the company is positioned to transform genetic medicine and improve patient care through its groundbreaking technology.
Epirus, Inc. specializes in the design and development of advanced artificial intelligence-based defense systems aimed at countering drones and asymmetric technologies. Founded in 2018 and located in Hawthorne, California, the company produces high-powered microwave products, including its flagship technology, ELECTROMAGNETIC PULSE, which serves as a drone countermeasure. This innovative solution employs multiple simultaneous beams to neutralize unmanned aircraft systems, while also utilizing software-defined electromagnetic pulse technology to enhance its effectiveness. By integrating computer vision and machine learning, Epirus aims to optimize the detection and tracking of various threats, providing defense organizations with the capability to stun drones or disrupt swarms effectively. The company's products address critical national security challenges in both defense and commercial sectors.
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.
Redwood Materials, Inc. is a recycling and materials processing company based in Carson City, Nevada, founded in 2017. The company specializes in developing sustainable methods for recycling various metals and materials, particularly from batteries and electronics, to support circular supply chains. Its focus includes lithium, nickel, copper, gold, silver, cobalt, and other critical elements used in electric vehicles, renewable energy storage, and consumer electronics. By providing environmentally sound recycling solutions, Redwood Materials aims to address the increasing demand for battery end-of-life management as the number of electric vehicles rises globally. The company's innovative technology not only recycles waste but also generates essential raw materials, enabling manufacturers to create sustainable products and significantly contributing to the transition towards a circular economy.
Element Biosciences, Inc. develops genetic analysis tools for the research and diagnostic markets. The company provides a disruptive DNA sequencing technology and a sequencing platform, such as surface chemistry, sequencing chemistry, detection, and data analysis. The company was incorporated in 2017 and is based in San Diego, California.
Jetti Resources is a Canadian company founded in 2014, headquartered in Vancouver, specializing in the development of hydrometallurgical technology for metal extraction from mineral ores. The company focuses on extracting copper from low-grade primary sulfides, particularly chalcopyrite, the most abundant copper mineral ore. Jetti's proprietary catalytic technology effectively addresses the challenges associated with recovering vast amounts of trapped resources, significantly enhancing copper yields while being cost-effective and environmentally responsible. In addition to copper, the technology can also be applied to the extraction of zinc and nickel from sulfide ores, contributing to more efficient mineral processing practices.
Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company offers a comprehensive food analytics platform that utilizes next-generation sequencing to analyze the molecular contents of foods and ingredients. This platform provides food manufacturers, suppliers, and retailers with crucial transparency across supply chains, testing products for authenticity, contaminants, allergens, and various other factors such as GMOs, heavy metals, and nutrition. Clear Labs also focuses on simplifying complex diagnostics for clinical and applied markets, combining DNA sequencing, robotics, and cloud-based analytics to improve accuracy and accelerate outcomes. By delivering insights into food safety and quality, Clear Labs aims to enhance understanding and management of potential health risks associated with food products and emerging pathogens.
Gyroscope is an ophthalmology company developing gene therapies for the treatment of eye diseases linked to an unbalanced complement system. Gyroscope was founded to explore the convergence of advancements made in the understanding of the complement system’s impact on eye disease, the genetic basis of Age-related Macular Degeneration (AMD) and gene therapy as a mode of treatment delivery.
Insitro, Inc. is a data-driven drug discovery and development company based in South San Francisco, California, founded in 2018. The company utilizes machine learning and high-throughput biology to transform the traditional processes of drug discovery and delivery. By generating extensive functional genomic datasets and aligning them with patient data through innovative machine learning techniques, Insitro builds predictive models that aim to address critical challenges in pharmaceutical research and development. These models facilitate accelerated target selection and the design of effective therapeutics, ultimately enhancing the efficiency of drug development and informing clinical strategies. The focus of Insitro's work includes the treatment of nonalcoholic steatohepatitis (NASH), showcasing its commitment to addressing significant health issues through advanced technology.
Tenaya Therapeutics is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for heart disease, particularly heart failure. Established in 2016, the company employs three main platforms to address the underlying causes of heart disease: a cellular regeneration platform that reprograms cardiac fibroblasts into cardiomyocytes using proprietary transcription factors, a gene therapy platform for targeted delivery of therapeutic payloads, and a precision medicine approach tailored to individual patients. Through these platforms, Tenaya Therapeutics aims to enable the regeneration of heart tissue and tackle various forms of cardiomyopathies, leveraging advanced research in cardiac development and regeneration.
Vividion Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing therapeutics to address significant unmet medical needs. The company utilizes a novel platform for proteome-wide small molecule drug discovery, which combines proteomic techniques and synthetic chemistry to enhance drug selectivity and broaden the range of druggable proteins. Originating from research at The Scripps Research Institute, Vividion's technology enables the creation of detailed drug interaction maps, facilitating simultaneous target engagement and comprehensive selectivity profiling. By advancing its innovative synthetic and proteomic chemistry approaches, Vividion aims to deliver transformative treatments for patients with serious illnesses.
Rad Power Bikes LLC is a Seattle-based manufacturer of electric bicycles, established in 2015. The company specializes in designing and selling feature-rich e-bikes intended for both on and off-road use, focusing on comfort and utility. Rad Power Bikes operates a direct-to-consumer model, enabling customers to purchase their products online at competitive prices. In addition to electric bicycles, the company offers a range of accessories, including storage bags, fenders, racks, and safety products, as well as replacement parts such as batteries and tires. Rad Power Bikes is committed to making sustainable transportation accessible to a wide audience.
Affinivax, Inc. is a biotechnology company based in Lexington, Massachusetts, that specializes in developing vaccines using its innovative Multiple Antigen Presenting System (MAPS) technology. This approach allows for the combination of protective polysaccharides and proteins in a single vaccine, aiming to enhance the immune response against various infectious diseases. Affinivax focuses on a range of pathogens, including Streptococcus pneumoniae, which poses significant health risks to both children and adults. The company seeks to create vaccines that provide broader disease coverage and address infectious diseases lacking effective immunization strategies. Founded in 2014, Affinivax benefits from insights provided by leading experts in infectious diseases and vaccines, and it has secured support from the Bill & Melinda Gates Foundation, along with exclusive licensing rights from Boston Children’s Hospital for its MAPS technology.
FogPharma is a healthcare company founded in 2015 and headquartered in Gloucester, Massachusetts. The firm is dedicated to the pharmaceutical sector, with a primary focus on developing innovative treatments for cancer. It operates with the support of a diverse group of private and institutional investors, fostering collaboration among its founders, employees, and advisors. FogPharma aims to create a new class of medicines designed to extend and enhance the lives of cancer patients. The company's commitment to its mission drives its efforts to pioneer effective solutions in cancer treatment.
FLEXE, Inc. operates a cloud-based warehousing services marketplace that connects organizations needing additional storage and fulfillment capacity with those that have surplus space. Founded in 2013 and based in Seattle, Washington, the company provides a platform that facilitates efficient warehouse sourcing and setup, streamlining material handling operations for clients including retailers, wholesalers, manufacturers, and logistics firms. By addressing inventory overflow and fulfillment challenges, FLEXE enhances the logistics industry and enables businesses to achieve greater structural flexibility in their operations. The company aims to optimize the global delivery of goods and improve access to affordable warehousing solutions, ultimately helping enterprises strengthen their distribution networks and maximize revenue potential.
Imago BioSciences is a clinical-stage biotechnology company based in San Carlos, California, focused on developing innovative therapies for hematologic diseases, including leukemia and myelodysplastic syndromes. Established in 2012, the company specializes in small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme crucial for blood cell production in the bone marrow. Its lead candidate, Bomedemstat, is an orally available inhibitor of LSD1, being evaluated for its potential to modify the disease course in patients with myeloproliferative neoplasms, a group of chronic bone marrow cancers. Imago aims to translate advanced scientific insights into effective treatments that can significantly improve the quality and duration of life for patients facing these challenging conditions.
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the manufacture of self-driving vehicles designed for local goods transportation. Incorporated in 2016, Nuro focuses on transforming local commerce through autonomous delivery services. The company operates a fleet of electric, fully autonomous vehicles capable of delivering a wide range of products, from food to pharmaceuticals. Nuro's mission is to enhance everyday life by providing quick, affordable, and safe delivery solutions for merchants and their customers.
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.
Alignment Healthcare is dedicated to transforming the complex and confusing process of medical treatment so that every link in the healthcare continuum becomes more efficient, productive and effective. The company partners with providers, health plans and hospitals to create a seamless, fast and easy-to-navigate healthcare experience, which results in happier, healthier and more satisfied patients. Based in Irvine, California, Alignment Healthcare provides partners with an end-to-end continuous care program, including clinical care coordination, risk management capabilities, and IT enablement
Generation Bio is a genetic medicines company based in Cambridge, Massachusetts, that specializes in developing gene therapies aimed at treating both rare and prevalent diseases. Established in 2016, the company focuses on conditions affecting the liver, retina, skeletal muscle, central nervous system, and oncology. Generation Bio employs an innovative non-viral platform that includes a proprietary high-capacity DNA construct known as closed-ended DNA (ceDNA), a cell-targeted lipid nanoparticle delivery system (ctLNP), and a scalable, capsid-free manufacturing process. This approach allows for the targeted delivery of genetic materials, including large and multiple genes across various tissues, and enables redosable treatments tailored to individual patient needs. By enhancing access to therapies for rare diseases and addressing more common conditions, Generation Bio aims to provide durable and sustainable treatment options for patients throughout their lives.
Allbirds, Inc. is a San Francisco-based company founded in 2015 that specializes in manufacturing eco-friendly footwear and apparel. The company offers a range of products, including wool runners, tree runners, tree loungers, tree skippers, and insoles for men, women, and children. Allbirds is committed to sustainability, utilizing premium natural materials to create comfortable and well-designed shoes that align with its mission of reducing environmental impact. The brand distinguishes itself by emphasizing thoughtfulness over flash in the footwear industry. Products are sold through a combination of physical stores and online platforms, with a significant portion of revenue generated from sales within the United States.
Convoy, Inc. operates an online marketplace that provides digital freight network services, facilitating the transportation of goods across the United States. Founded in 2015 and based in Seattle, Washington, the company allows users to book local and regional trucks on demand, accommodating loads ranging from a single pallet to full truckloads. Convoy's platform includes features such as instant quotations, online booking, automated loading suggestions, and real-time shipment tracking, enhancing operational efficiency for shippers. The company aims to address inefficiencies in the trucking industry, which faces significant carbon waste from empty trucks, by leveraging technology and data. Convoy collaborates with major clients, including Fortune 500 companies, to lower logistics costs and meet sustainability goals while improving earnings for drivers.
Gusto is a company that provides a cloud-based platform designed for small and medium-sized businesses to manage payroll, benefits, and human resources. Founded in 2011 and headquartered in San Francisco, with an additional office in Denver, Gusto offers an array of services including payroll processing, health benefits, workers' compensation, and time tracking. The platform allows employers and employees to access payroll information from various devices, enabling features such as browsing pay stubs, reviewing tax forms, and verifying personal details. Gusto caters to a diverse clientele, including startups, coffee shops, medical practices, creative agencies, and law firms, aiming to simplify the administrative tasks associated with employee management.
Framebridge, Inc. specializes in custom framing solutions for art and photographs, offering a streamlined online service that prioritizes customer experience. Founded in 2014 and based in Washington, D.C., the company allows users to select from a curated range of contemporary frame styles, upload images, or send physical items for personalized framing. The expert team at Framebridge handcrafts frames to meet each customer's specifications, ensuring high-quality results. Finished products are shipped directly to consumers, typically arriving within days and ready to hang. Pricing is transparent and based on the size of the framed item, starting at $39 and including free shipping. Framebridge operates manufacturing facilities in Richmond, Kentucky, and Lanham, Maryland, and has attracted investments from notable firms and individuals in the retail and technology sectors.
Checkr, Inc. is a technology company that specializes in background check services. Founded in 2014 and headquartered in San Francisco, California, Checkr offers a range of screening services, including criminal record checks, driving checks, and identity verification, all delivered through an advanced platform that can provide faster turnaround times compared to traditional background check providers. The company utilizes artificial intelligence and machine learning to enhance the hiring process, ensuring compliance and improving the applicant experience. Checkr serves various industries, including financial services, healthcare, retail, and technology, by providing tools that help organizations navigate the complexities of workforce dynamics while promoting transparency and fairness in hiring. Additionally, Checkr offers security solutions, continuous monitoring, and a unified identity verification service, Checkr Connect IDV, which integrates identity verification with background checks.
RefleXion Medical Inc. specializes in developing a biologically-guided radiotherapy system aimed at transforming cancer treatment. The company’s innovative technology allows tumors to continuously signal their location during therapy, facilitating the simultaneous treatment of multiple tumors, particularly in cases of metastasis. The RefleXion X1 machine is currently cleared for various forms of radiotherapy, including stereotactic body radiotherapy (SBRT) and intensity-modulated radiotherapy (IMRT). At the core of RefleXion's approach is the integration of positron-emission tomography (PET) imaging, which enables real-time tumor tracking and dose adaptation based on the biological characteristics of the tumors. This advancement in radiotherapy promises to enhance precision in cancer treatment, offering a potential paradigm shift in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic collaborations, including partnerships with Telix Pharmaceuticals and HealthMyne.
Shockwave Medical, Inc. is a medical device company that specializes in intravascular lithotripsy technology aimed at treating calcified plaque in patients with various cardiovascular diseases. The company has developed the Lithoplasty™ family of balloon dilatation catheters, which incorporate lithotripsy electrodes to enhance the compliance of rigid vascular and valvular lesions before low-pressure dilation. This approach minimizes injury to healthy tissue and addresses limitations associated with traditional revascularization technologies. Shockwave offers specific catheters for different applications, including M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. The technology is designed to facilitate more effective angioplasty and improve stent delivery, as well as enhance native tissue preparation for trans-catheter aortic valve replacement. Founded in 2009 and headquartered in Santa Clara, California, Shockwave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists across the United States and internationally.
Wheels Up is a membership-based private aviation company that focuses on reducing the upfront cost to fly privately, providing flexibility, service, and safety. Its mobile app enables members to book flights, manage their accounts, and participate in ride-share opportunities. Its members also have given access to the Wheels Down program. The company was founded in 2013 and headquartered in New York, United States.
Evolve Vacation Rental Network, Inc. operates a marketing and booking platform that offers vacation rental management services for both guests and homeowners. Founded in 2010 and based in Denver, Colorado, the company allows homeowners to effectively market and manage their vacation properties online. Evolve provides a range of services, including professional property listings, marketing, guest communications, and local service provider information. By leveraging a network of vetted local partners, Evolve ensures that essential services such as housekeeping and maintenance are efficiently handled. This approach enables homeowners to achieve higher rental income at reduced costs compared to traditional property management options, while also enhancing the travel experience for guests.
Outset Medical, Inc. is a medical technology company that specializes in developing advanced hemodialysis systems for both acute and chronic patient care. The company's flagship product, the Tablo Hemodialysis System, is a compact and user-friendly dialysis machine designed to provide efficient care in various settings. Tablo integrates essential features such as water purification, on-demand dialysate production, and connectivity capabilities, making it versatile and convenient for healthcare providers. With its wireless data transmission, sensor-based automation, and an intuitive animated touchscreen, Tablo aims to enhance the patient care experience while driving innovation in service models to reduce costs. Founded in 2003 and headquartered in San Jose, California, Outset Medical was previously known as Home Dialysis Plus, Ltd. until its rebranding in 2015.
Home Dialysis Plus, Ltd. provides home hemodialysis solutions to patients and their healthcare providers. Its dialysis system enables hemodialysis treatment in the homes of patients. Home Dialysis Plus, Ltd. was founded in 2003 and is based in Portland, Oregon.
Shockwave Medical, Inc. is a medical device company that specializes in intravascular lithotripsy technology aimed at treating calcified plaque in patients with various cardiovascular diseases. The company has developed the Lithoplasty™ family of balloon dilatation catheters, which incorporate lithotripsy electrodes to enhance the compliance of rigid vascular and valvular lesions before low-pressure dilation. This approach minimizes injury to healthy tissue and addresses limitations associated with traditional revascularization technologies. Shockwave offers specific catheters for different applications, including M5 catheters for above-the-knee peripheral artery disease, C2 catheters for coronary artery disease, and S4 catheters for below-the-knee peripheral artery disease. The technology is designed to facilitate more effective angioplasty and improve stent delivery, as well as enhance native tissue preparation for trans-catheter aortic valve replacement. Founded in 2009 and headquartered in Santa Clara, California, Shockwave Medical serves interventional cardiologists, vascular surgeons, and interventional radiologists across the United States and internationally.
OfferUp provides an online and mobile C2C marketplace app for people to buy and sell electronics, furniture, and cars.
It enables users to post items for sale to friends, followers, people nearby, people of similar interests, moms groups, and craigslist using phones or tablets, browse local items with new postings daily; and message buyers and sellers.
Arean Van Veelen and Nick Huzar founded it in 2011, with its headquarters in Bellevue in Washington.
Magic Leap is a US-based startup specializing in augmented reality (AR) technology that aims to transform user interaction with digital devices. The company develops a mixed reality computing platform that merges the digital and physical worlds through advanced three-dimensional imagery. Its proprietary headset utilizes Dynamic Digitized Lightfield Signal technology to create images that are indistinguishable from real objects, seamlessly integrating them into the user's environment. By combining users' natural visual capabilities with mobile computing, Magic Leap offers a unique AR experience that redefines how individuals engage with screens and visualize data. The system is designed to harmonize with human senses, allowing for an immersive and visually cinematic interaction with digital content.
Audentes Therapeutics is a clinical-stage biotechnology company dedicated to developing and commercializing gene therapy products for patients with serious, life-threatening rare diseases caused by single gene defects. The company is advancing several therapies, including AT132, currently in Phase I/II clinical trials for X-linked myotubular myopathy, and AT342, also in Phase I/II studies for Crigler-Najjar syndrome. Additionally, Audentes is exploring AT845 in preclinical studies for Pompe disease and AT307 for the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia. The company is also working on vectorized antisense treatments for Duchenne muscular dystrophy and myotonic dystrophy type 1. Collaborations include a partnership with Genethon for XLMTM treatments and an agreement with the University of Pennsylvania for Crigler-Najjar syndrome products. Founded in 2012 and headquartered in San Francisco, California, Audentes Therapeutics operates as a subsidiary of Astellas US Holding, Inc.
OfferUp provides an online and mobile C2C marketplace app for people to buy and sell electronics, furniture, and cars.
It enables users to post items for sale to friends, followers, people nearby, people of similar interests, moms groups, and craigslist using phones or tablets, browse local items with new postings daily; and message buyers and sellers.
Arean Van Veelen and Nick Huzar founded it in 2011, with its headquarters in Bellevue in Washington.
Doximity is a digital platform that serves as the largest professional medical network in the United States, connecting over 70 percent of U.S. physicians. Founded in 2011 and based in San Francisco, Doximity provides a suite of tools designed specifically for medical professionals, including physicians, nurse practitioners, physician assistants, and registered nurses. The platform facilitates secure communication among healthcare providers, enabling them to collaborate on patient care, conduct virtual visits, and stay informed about the latest medical news and research. Additionally, Doximity offers resources to help medical professionals manage their careers effectively.
Domo, Inc. operates a cloud-based platform that connects various levels of an organization, from executives to front-line employees, with real-time data and insights. Founded in 2010 and headquartered in American Fork, Utah, Domo enables users to manage their business operations through smartphones, facilitating instant access to critical information. The platform includes features such as a Programmatic Revenue Solution, which integrates complex data from ad servers and sell-side platforms into user-friendly dashboards. Domo's services are offered on a subscription basis, generating revenue from both subscriptions and professional services, while also providing users with timely notifications that allow for immediate action on data-driven insights.
Dropbox is a prominent provider of secure file sharing, collaboration, and storage solutions, catering primarily to individuals and small to medium-sized businesses. Founded in 2007 by Drew Houston and Arash Ferdowsi, Dropbox has established itself as a pioneer in cloud storage and cross-platform file syncing. The company is headquartered in San Francisco, California, and operates more than 12 offices globally. With 500 million registered users, Dropbox facilitates seamless collaboration through its platform, allowing users to work from any device and location. Additionally, Dropbox for Business offers enhanced features, including robust administrative controls and secure file sharing tailored for organizational needs. As the company evolves, it is diversifying its product offerings to extend beyond traditional cloud storage solutions.
TrialPay, Inc. specializes in cross-platform monetization solutions, allowing customers to pay for one item by trying or purchasing another. Founded in 2006 and headquartered in Mountain View, California, with an additional office in Berlin, Germany, the company offers tools such as Evergreen, which helps developers create custom monetization strategies and connect with customers across various platforms, including the Web, mobile, and social networks. TrialPay's system facilitates free trials and promotional offers for merchants, enabling them to engage users through deals with advertising partners. As of March 2015, TrialPay operates as a subsidiary of Visa Inc.
Peixe Urbano is an online platform based in Florianópolis, Brazil, that allows users to discover and book deals across various sectors, including restaurants, beauty services, entertainment, and travel. Founded in 2010, the platform facilitates connections between consumers and local businesses, helping restaurants and service providers enhance their visibility and attract more customers. Peixe Urbano has gained recognition in the tech industry, notably being awarded "Best International Startup of the Year" at the Crunchies Awards. The company continues to serve as a valuable resource for users seeking discounts and promotions tailored to their preferences and location.
Zynga Inc. is a prominent developer and operator of social games, offering live services that are accessible on mobile platforms and social networking sites. Founded in 2007 and headquartered in San Francisco, California, Zynga markets popular game franchises, including Slots, Words With Friends, Zynga Poker, and FarmVille. The company's games are available on platforms such as iOS, Android, Facebook, and Snapchat. Zynga generates revenue primarily through mobile game downloads and in-game sales of virtual goods, with a significant portion also coming from advertising services provided to agencies and brokers. The majority of its revenue is derived from online gaming, with its top three games contributing substantially to this segment. Zynga's focus on engaging users through social gaming continues to position it as a leader in the interactive entertainment industry.
Portola Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, founded in 2003. It specializes in developing and commercializing innovative therapeutics primarily aimed at treating thrombosis, hematologic disorders, and inflammation. The company's lead product is Andexxa, an antidote for the anticoagulants rivaroxaban and apixaban. Additionally, Portola offers Bevyxxa, a once-daily oral Factor Xa inhibitor designed to prevent venous thromboembolism in adults with acute medical conditions. The firm is also developing several investigational products, including cerdulatinib, an oral dual inhibitor for hematologic cancers, and other compounds targeting chronic inflammatory diseases and cardiovascular conditions. Portola engages in collaborative agreements with various pharmaceutical companies to enhance its research and development efforts. As of July 2020, it operates as a subsidiary of Alexion Pharmaceuticals, Inc.
Portola Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, founded in 2003. It specializes in developing and commercializing innovative therapeutics primarily aimed at treating thrombosis, hematologic disorders, and inflammation. The company's lead product is Andexxa, an antidote for the anticoagulants rivaroxaban and apixaban. Additionally, Portola offers Bevyxxa, a once-daily oral Factor Xa inhibitor designed to prevent venous thromboembolism in adults with acute medical conditions. The firm is also developing several investigational products, including cerdulatinib, an oral dual inhibitor for hematologic cancers, and other compounds targeting chronic inflammatory diseases and cardiovascular conditions. Portola engages in collaborative agreements with various pharmaceutical companies to enhance its research and development efforts. As of July 2020, it operates as a subsidiary of Alexion Pharmaceuticals, Inc.
Terabeam is an American company that designs and manufactures free-space optical transceivers for internet access in downtown areas. Terabeam was founded in 1997 and is located in Kirkland, Washington. As of August 29, 2008, the company operates as subsidiary of Renaissance Electronics & Communications LLC.